New peer-reviewed journal ESMO Gastrointestinal Oncology

Quoting ESMO – European Society for Medical Oncology on LinkedIn:

“ESMO Daily Reporter: Over the past few years, there have been significant advancements in the field of Gastrointestinal Oncology that were eagerly awaited. Recent key studies have proven the efficacy of targeted agents and immunotherapy in GI oncology, offering more treatment options for patients at any stage of the disease. This fast-evolving landscape is reflected in the new peer-reviewed journal ESMO Gastrointestinal Oncology where attention is given not only to novel treatment approaches but also to data on the molecular characteristics of GI cancers and their classification, Translational Research and Precision Oncology.

To learn more, read the interview with Florian Lordick.”

Source: ESMO – European Society for Medical Oncology/LinkedIn